<p>Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts</p>Ashenafi Bulle(KU Leuven), Jos van Pelt(The University of Texas Southwestern Medical Center)OncoTargets and TherapyJuly 1, 202010.2147/ott.s245134Cited by 16SaveCiteExport RISWatch citationsRelated PapersHuman pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality|Journal of Translational Medicine|2023|10Abstract A081: Resistance Mechanisms to Monotherapy RAS(ON) Multi-Selective Inhibitor Daraxonrasib (RMC-6236) in RAS Mutant PDAC Inform Therapeutic Combination Strategies|Molecular Cancer Therapeutics|2025|1